Search Results - "De Lemos, J.A"

Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy by Wayangankar, S.A, Roe, M.T, Chen, A.Y, Gupta, R.S, Giugliano, R.P, Newby, L.K, de Lemos, J.A, Alexander, K.P, Sanborn, T.A, Saucedo, J.F

“…Abstract Objective To analyze trends in utilization of anti-thrombotic agents (ATA) and in-hospital clinical outcomes in non-ST-elevation myocardial infarction…”
Get full text

Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions by Welsh, P, Welsh, C, Celis-Morales, C.A.C, Brown, R, Ferguson, L.D, Gray, S, Mark, P, Lewsey, J, Lyall, D.M, Gill, J.M.R, Pell, J, Jhund, P.S, De Lemos, J.A, Willeit, P, Sattar, N

“…Abstract Background Lipoprotein (a) (Lp(a)) measurement may help guide CVD risk prediction, is thought to be causal in several CVD outcomes, and phase 3…”
Get full text

Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort by Baber, U., de Lemos, J.A., Khera, A., McGuire, D.K., Omland, T., Toto, R.D., Hedayati, S.S.

“…The increased burden of cardiovascular disease in chronic kidney disease cannot be explained by traditional risk factors alone. Here, we evaluated the impact…”
Get full text

Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14 by Antman, E.M, Gibson, C.M, de Lemos, J.A, Giugliano, R.P, McCabe, C.H, Coussement, P, Menown, I, Nienaber, C.A, Rehders, T.C, Frey, M.J, Van der Wieken, R, Andresen, D, Scherer, J, Anderson, K, Van de Werf, F, Braunwald, E

“…Aims Abciximab has previously been shown to enhance thrombolysis and improve myocardial perfusion when combined with reduced doses of alteplase. The purpose of…”
Get full text

Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction. Insights from TIMI 14 and InTIME-II by Antman, E.M., Cooper, H.A., Gibson, C.M., de Lemos, J.A., McCabe, C.H., Giugliano, R.P., Coussement, P., Murphy, S., Scherer, J., Anderson, K., Van de Werf, F., Braunwald, E.

“…Background When evaluating new reperfusion regimens for ST elevation MI, it is important to adjust for factors that influence the likelihood of achieving…”
Get full text

Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction by Antman, A.M., de Lemos, J.A., Braunwald, E.

“…Recent evidence from the Thrombolysis in Myocardial Infarction (TIMI) 14 trial suggests that combining reduceddose fibrinolytic therapy with the potent…”
Get full text

Soluble CD40L: risk prediction after acute coronary syndromes by Varo, N, de Lemos, J.A, Libby, P

Get full text

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide by Sabatine, M.S., Morrow, D.A., de Lemos, J.A.

Get full text

The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes by De Lemos, J.A., Morrow, D.A., Bentley, J.H.

Get full text

Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia by Sabatine, M.S., Morrow, D.A., de Lemos, J.A.

Get full text

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: Results from the A phase of the A-to-Z trial by de Lemos, J.A., Blazing, M.A., Wiviott, S.D.

Get full text

Early intensive vs. a delayed conservative simvastatin strategy in patients with acute coronary syndromes by de Lemos, J.A., Blazing, M.A., Wiviott, S.D.

“…Study Question: Phase Z of the A to Z trial was designed to evaluate a strategy of early initiation of intensive treatment with simvastatin (80 mg) in ACS…”
Get full text

B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: An ENTIRE-TIMI-23 substudy by Mega, J.L., Morrow, D.A., de Lemos, J.A.

Get full text

Safety and efficacy of enoxaparin vs. unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes. who receive tirofiban and aspirin by Blazing, M.A., de Lemos, J.A., White, H.D.

Get full text

Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction B-type natriuretic peptide and prognosis in TACTICS-TIMI 18 by Morrow, D.A., de Lemos, J.A., Sabatine, M.S.

Get full text

Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram by De Lemos, J.A., Antman, E.A., Giugliano, R.P.

Get full text